Results 151 to 160 of about 99,768 (184)

Association of CSF Kappa-Free Light Chains With Cortical and Periventricular Brain Damage in Multiple Sclerosis. [PDF]

Neurology
Damulina A, Opriessnig P, Pirpamer L, Demjaha R, Tafrali C, Martinez-Serrat M, Hofer E, Wurth S, Heschl B, Hochmeister S, Archelos JJ, Pinter D, Ropele S, Enzinger C, Khalil M.   +14 more
europepmc   +1 more source

Chronic alcohol consumption downregulates TRPA1 ion channel and the main peptidergic messengers of the Edinger-Westphal nucleus. [PDF]

Sci Rep
Al-Omari A, Török I, Zsidó BZ, Hetényi C, Pintér E, Sándor Z, Berta G, Szocsics P, Gombás P, Biró-Sütő T, Gaszner B, Kormos V.   +11 more
europepmc   +1 more source

Health Literacy and Nutrition of Adolescent Patients with Inflammatory Bowel Disease. [PDF]

Nutrients
Pintér HK, Nagy VA, Csobod ÉC, Cseh Á, Béres NJ, Prehoda B, Dezsőfi-Gottl A, Veres DS, Pálfi E.   +8 more
europepmc   +1 more source

Advancing Bidirectional Photoswitching of Norbornadienes: Exclusively Light-Induced Interconversion of Imide- and Ortho-Connected Norbornadiene-Perylene Diimide Hybrids. [PDF]

Chemistry
Pintér S, Strassner NM, Krappmann D, Schulze EJ, Hirsch A.   +4 more
europepmc   +1 more source

Neuroimaging Markers Associated With Recurrent Stroke in Intracerebral Hemorrhage and Atrial Fibrillation: Secondary Analysis of PRESTIGE-AF. [PDF]

Neurology
Fandler-Höfler S, Ropele S, Gattringer T, Haidegger M, Pinter D, Kneihsl M, Korompoki E, Montaner J, Caso V, Ringleb PA, Sibon I, Halse O, Harvey K, Fießler C, Wolfe CDA, Heuschmann PU, Veltkamp R, Enzinger C, PRESTIGE-AF Consortium.   +18 more
europepmc   +1 more source

Behavioral Variation in Individual and Group Exploration of the Tropical Fire ant <i>Solenopsis geminata</i> (Hymenoptera: Formicidae). [PDF]

Zool Stud
Lai LC, Hsu CB.
europepmc   +1 more source

Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 (TYK2) inhibitor, in patients with moderate to severe scalp psoriasis: Efficacy and safety results through week 16 in a phase 3b/4, multicenter, randomized, double-blinded, placebo-controlled trial (PSORIATYK SCALP). [PDF]

JAAD Int
Duffin KC, Griffiths CEM, Hoffmann M, Blauvelt A, Balagula Y, Napoli A, Becker B, Jou YM, Dyme R, Hala V, Pinter A, Thaçi D, Gold LS, Lebwohl M.   +13 more
europepmc   +1 more source

Icotrokinra induces early and sustained pharmacodynamic responses in phase IIb study of patients with moderate-to-severe psoriasis. [PDF]

JCI Insight
Strawn D, Krueger JG, Bissonnette R, Eyerich K, Ferris LK, Paller AS, Pinter A, Richards D, Chen EY, Paget K, Horowitz D, Parast R, Rusbuldt JJ, Sendecki J, Bhagat S, Tomsho LP, Chou CH, Polak ME, Keyes BE, Bozenhardt E, Xiong Y, Zhou W, DeKlotz C, Newbold P, Waterworth DM, Miller M, Ota T, Yang YW, Leung MW, Miller LS, Cuff CA, McRae B, Ruane D, Kannan AK.   +33 more
europepmc   +1 more source

The Quill -- March 29, 1971 [PDF]

, 1971
Roger Williams University
core   +1 more source

Large Eczema Area and Severity Index response at 2-year follow-up of patients treated with dupilumab in routine care of atopic dermatitis: results from the national registry TREATgermany. [PDF]

Skin Health Dis
Heinrich L, Birkner T, Abraham S, Gerdes S, Honstein T, Müller S, Augustin M, Harder I, Schaefer T, Pinter A, Bong A, Ramaker-Brunke J, Biedermann T, Sticherling M, Gorriahn-Maiterth H, Schäkel K, Schwarz B, Quist S, Asefi M, Adler N, Stahl M, Schulz-Kiesow M, Schenck F, Werfel T, Weidinger S, Heratizadeh A, Schmitt J.   +26 more
europepmc   +1 more source